Fresenius Medical Care AG & Co. KGaA (FME) PT Set at €90.00 by HSBC

Share on StockTwits

HSBC set a €90.00 ($104.65) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note released on Tuesday. The brokerage currently has a buy rating on the stock.

A number of other equities research analysts have also commented on the company. JPMorgan Chase & Co. set a €97.90 ($113.84) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Tuesday, October 30th. Deutsche Bank set a €107.00 ($124.42) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Friday, October 5th. UBS Group set a €82.00 ($95.35) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Friday, October 26th. Barclays set a €87.20 ($101.40) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research report on Friday, September 28th. Finally, Nord/LB set a €85.00 ($98.84) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Wednesday, October 17th. Nine analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The stock presently has an average rating of Buy and a consensus target price of €87.95 ($102.27).

ETR FME opened at €68.00 ($79.07) on Tuesday. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €75.53 ($87.83) and a 12 month high of €93.82 ($109.09).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Read More: Market Capitalization

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

CubeSmart  Given Consensus Recommendation of “Buy” by Brokerages
CubeSmart Given Consensus Recommendation of “Buy” by Brokerages
GOLD Reward Token  One Day Volume Hits $220.00
GOLD Reward Token One Day Volume Hits $220.00
Dean Foods Co  Expected to Announce Earnings of -$0.27 Per Share
Dean Foods Co Expected to Announce Earnings of -$0.27 Per Share
NWQ Investment Management Company LLC Has $4.67 Million Holdings in Total SA
NWQ Investment Management Company LLC Has $4.67 Million Holdings in Total SA
Embotelladora Andina SA ADR Series A  vs. Fomento Economico Mexicano SAB  Critical Comparison
Embotelladora Andina SA ADR Series A vs. Fomento Economico Mexicano SAB Critical Comparison
HANNOVER RUECK/S  & Genworth Financial  Financial Analysis
HANNOVER RUECK/S & Genworth Financial Financial Analysis


Leave a Reply

 
© 2006-2018 Zolmax.